Anti-hypertensives: Patent Defense Strategies - Combating Generic Competition Through Lifecycle Management - Market Research Reports

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/988

Anti-hypertensives: Patent Defense Strategies - Combating Generic Competition Through Lifecycle Management

Description:

It is evident that patents provide an incentive for pharmaceutical companies to invest in research and development (R&D), since they enable companies to recoup the money spent during the development and launch of a new product. However, once patents expire, generic competition tends to result in a dramatic decline in the sales of the branded product and, therefore, companies are developing increasingly sophisticated strategies for defending and competing against generic competition. This brief will focus on the effect of patent expiries, both past and future, on the anti-hypertensives market since this is the largest pharmaceutical market in terms of value and constitutes a crucial component of the portfolio of the leading cardiovascular companies. However, although the brief concentrates on the anti-hypertensives market, which is already highly genericized and currently facing another major round of patent expiries, many of the principles outlined can be applied to other markets.

Contents:

EXECUTIVE SUMMARY

INTRODUCTION

THE IMPORTANCE OF LIFECYCLE MANAGEMENT

THE ANTI-HYPERTENSIVES MARKET

Overview of the market

A core component of a cardiovascular portfolio

The need for lifecycle management in the anti-hypertensives market

Recent, ongoing and future patent expiries in the anti-hypertensives market

Defending against generic competition

Planning and implementation of defense strategies

Additional indications

Competitive pricing

Launch of a generic product

New formulations

Pediatric extensions

Portfolio management

Regulatory benefits

Litigation

Case studies

Bayer's Adalat (nifedipine): a successful model of lifecycle management

Andrx's diltiazem: inventing round Cardizem's patent

Bristol-Myers Squibb's Capoten (captopril): unable to compete following patent expiry

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/988

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 12/10/2008 12:48:04

Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com

Order information

Please verify that the product information is correct and select the format you require.


Product Name:
Anti-hypertensives: Patent Defense Strategies - Combating Generic Competition Through Lifecycle Management
Web Address:
http://www.researchandmarkets.com/reports/988
Office Code:
OCHKFKJQSTX

Report formats

Please enter the quantity of the report format you require.

Format	Quantity	Price
Hard Copy		€1,669.00 + EUR€ 50.00 Shipping/Handling *
Electronic		€1,605.00
Electronic - Site License		€1,605.00

* Shipping/Handling is only charged once per order.

Contact information

Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Page 2 of 2
Printed 12/10/2008 12:48:04

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder Name:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World